NASDAQ: CAPR

Capricor Therapeutics Inc (CAPR) is ready for next Episode as it posted an annual sales of 22,270 K
On Monday, Capricor Therapeutics Inc (NASDAQ: CAPR) was 24.30% up from the session before settling in for the closing price ...

Capricor Therapeutics Inc (CAPR) plunge -10.05% in a week: will this be a lucky break through?
Capricor Therapeutics Inc (NASDAQ: CAPR) open the trading on Thursday, with great promise as it jumped 12.83% to $5.19, before ...

Investors must take note of Capricor Therapeutics Inc’s (CAPR) performance last week, which was -8.91%.
On Friday, Capricor Therapeutics Inc (NASDAQ: CAPR) opened lower -5.57% from the last session, before settling in for the closing ...

CAPR (Capricor Therapeutics Inc) dropped -6.76 at the last close: Is This Today’s Most Popular Stock?
Capricor Therapeutics Inc (NASDAQ: CAPR) kicked off on Monday, down -6.76% from the previous trading day, before settling in for ...

Capricor Therapeutics Inc (CAPR) is 4.15% away from 50-day simple Moving Average despite all headwinds
Capricor Therapeutics Inc (NASDAQ: CAPR) open the trading on Wednesday, with great promise as it jumped 11.97% to $6.92, before ...

-25.66% percent quarterly performance for Capricor Therapeutics Inc (CAPR) is not indicative of the underlying story
On Friday, Capricor Therapeutics Inc (NASDAQ: CAPR) opened lower -7.65% from the last session, before settling in for the closing ...

Capricor Therapeutics Inc (CAPR) with a beta value of 0.67 appears to be a promising investment opportunity.
On Friday, Capricor Therapeutics Inc (NASDAQ: CAPR) was 8.74% up from the session before settling in for the closing price ...





